A multicenter random assignment phase II study of irinotecan and flavopiridol versus irinotecan alone for patients with p53 wild-type gastric adenocarcinoma (NCI 8060) Meeting Abstract
| Authors: | Janjigian, Y. Y.; Tang, L. H.; Shibata, S.; Kelsen, D. P.; Segal, M.; Cheng, C.; Schwartz, G. K.; Doyle, L. A.; Shah, M. A. |
| Abstract Title: | A multicenter random assignment phase II study of irinotecan and flavopiridol versus irinotecan alone for patients with p53 wild-type gastric adenocarcinoma (NCI 8060) |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009804900 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.e14586 |
| Notes: | Meeting Abstract: e14586 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work